APA

Achhra A. C., Boyd M. A., Law M. G., Matthews G. V., Kelleher A. D. & Cooper D. A. (20151026). Moving away from Ritonavir, Abacavir, Tenofovir, and Efavirenz (RATE)--agents that concern prescribers and patients: a feasibility study and call for a trial. : PloS one.

Chicago

Achhra Amit C, Boyd Mark A, Law Matthew G, Matthews Gail V, Kelleher Anthony D and Cooper David A. 20151026. Moving away from Ritonavir, Abacavir, Tenofovir, and Efavirenz (RATE)--agents that concern prescribers and patients: a feasibility study and call for a trial. : PloS one.

Harvard

Achhra A. C., Boyd M. A., Law M. G., Matthews G. V., Kelleher A. D. and Cooper D. A. (20151026). Moving away from Ritonavir, Abacavir, Tenofovir, and Efavirenz (RATE)--agents that concern prescribers and patients: a feasibility study and call for a trial. : PloS one.

MLA

Achhra Amit C, Boyd Mark A, Law Matthew G, Matthews Gail V, Kelleher Anthony D and Cooper David A. Moving away from Ritonavir, Abacavir, Tenofovir, and Efavirenz (RATE)--agents that concern prescribers and patients: a feasibility study and call for a trial. : PloS one. 20151026.